As the pharmaceutical industry evolves, contract development and manufacturing organizations (CDMOs) are facing increasing pressure to scale efficiently while maintaining quality, compliance, and client trust. Growth alone is no longer enough—success depends on how well organizations integrate systems, processes, and teams to deliver consistent, high-quality outcomes across a global footprint.
In this Adare Pharma Solutions resource, developed in collaboration with Gryphon Citadel, we explore the structural and strategic challenges CDMOs encounter as they scale. From digital transformation and enterprise orchestration to emerging technologies like 3D screen printing, this piece highlights what it takes to move from fragmented growth to truly integrated, future-ready operations.
